Resonant

Membership Level: Standard Community

Resonant is a disruptive neurodegenerative disease biotechnology company that develops groundbreaking blood tests that accurately detect and monitor DNA from dying neurons. This DNA serves as biomarkers of neurodegeneration in diseases like Alzheimer’s and may be predictive of neurodegenerative diagnoses before clinical symptoms appear. Resonant is currently conducting a large-scale clinical validation study of its tests for Alzheimer’s, Parkinson’s, and ALS with plans to develop tests for other neurodegenerative conditions such as traumatic brain injury and multiple sclerosis.

More